WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

	What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Co...
	Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on the lessons from the new normal of Chinese pharma and pos... (2/28/2020)

How to Use Chinese Policies Rolled Out amid COVID-19 (4/3/2020)

NMPA Finalizes Two Implementing Rules of the Drug Administration Law (4/2/2020)

Be Ready for the Dire Aftermath of the Post-Outbreak China Market (4/1/2020)

Bloomberg: Virus Likely Curtailed China Drug Output, Raising Shortage Fears (3/25/2020)

Amid Outbreak, French Economy’s Dependency on China in the Spotlight (3/25/2020)

Novel Coronavirus (COVID-19) Presents New Legal Challenges in China (3/24/2020)

CNBC: Peter Navarro Slams Big Pharma's Lobbying against Possible 'Buy America' Executive Order (3/20/2020)

EUCCC Reports Joint Survey Results on Impacts of COVID-19 on European business in China (3/15/2020)

Highlights of China's New Implementing Regulations for the Foreign Investment Law (3/12/2020)

Global Companies Expand the Reach of Their Cancer Drugs in China (3/11/2020)

The Coronavirus Long Battle: Trump Admin To Attack China’s Pharmaceutical Supply Chains (3/11/2020)

AmCham China Releases Extended COVID-19 Flash Survey Report (3/6/2020)

IQVIA Looks into The Epidemic Impact on China Healthcare Industry (3/6/2020)

What Are the Lessons To Be Drawn from China's New Normal and the Latest Novel Coronavirus Crisis? (2/28/2020)

McKinsey Assesses Impacts of Covid-19 on China Healthcare (2/26/2020)


	Recent Executive Moves (4/3/2020)
	Ansun Bio Announces Positive Results fro... (4/3/2020)
	Henlius Novel Anti-EGFR mAb Shows Positi... (4/3/2020)
	Sareum Outlicenses Leukemia Drug to Chin... (4/3/2020)
	Genechem Raises CNY 400M from Domestic I... (4/3/2020) (free)
	NMPA Issues Announcement on Contemporary... (4/3/2020)
	NMPA Holds Teleconference for Major Drug... (4/3/2020)
	CDE Solicits Public Comments for Clinica... (4/2/2020)
	Tsinghua: COVID-19 Vaccine and Antibodie... (4/2/2020) (free)
	Eisai in Deal to Distribute Seikagaku's ... (4/2/2020)
	BeyondSpring Initiates NDA Rolling Submi... (4/1/2020)
	Chinese Scientists: Several 'Extremely E... (4/1/2020)
	Chinese Coronavirus Vaccine May Be Teste... (4/1/2020)
	Innovent and Alector Enter Licensing Dea... (4/1/2020)
	Shionogi Forms Chinese JV with Ping An t... (4/1/2020)

	Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
	PhRMA Calls for Trade Deals That Force Countries to Pay ...
	IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
	Pfizer and GSK Announce JV to Create a Global Consumer H...
	Top 25 Global Pharmaceutical Companies by Market Cap 201...

	Chinese Transmucosal Drug Delivery Systems Market to Rise 11% C...
	GlobalData Predicts CAGR 4.1% for APAC Axial Spondyloarthritis ...
	Snapshot of Chinese Urban Rep Hospital Drug Market in 2019
	Snapshot of Chinese VMS OTC Market in MAT 09/2019
	Chinese Oncology Drug Market to Rise 8.7% CAGR Before 2026: New...

	Sareum Outlicenses Leukemia Drug to Chinese Firm
	Genechem Raises CNY 400M from Domestic Investors
	Eisai in Deal to Distribute Seikagaku's Osteoarthritis Drug ...
	Innovent and Alector Enter Licensing Deal for Latter's Oncol...
	Shionogi Forms Chinese JV with Ping An to Develop New Drugs

	NMPA Issues Announcement on Contemporary Drug Distributi...
	NMPA Holds Teleconference for Major Drug Post-Marketing ...
	CDE Solicits Public Comments for Clinical Research Guide...
	NMPA Announcement on Implementation of the Amended Provi...
	NMPA Announcement on Implementation of the Amended Provi...

	BrightGene Censured for False Claim on Gilead's Coronavirus ...
	USTR's 2019 Report for China's WTO Compliance Highlight IP a...
	Cardinal Health Settles with SEC for China-linked FCPA Alleg...
	Beijing High Rejects Novartis' Trademark Registration of "Al...
	Gilead's Antiviral Remdesivir Granted Three Patents in China...

	China Claims Resumption of API Manufacture as Freight an...
	China Vows to Further Stabilize Production, Supply of Ac...
	China Begins Export of Many Pharma Ingredients to India
	U.S. Eyes Puerto Rico As Alternative to Chinese APIs
	China-controlled Penicillin G API Sees over 50% Price Hi...

	Ansun Bio Announces Positive Results from Trial of Novel...
	Henlius Novel Anti-EGFR mAb Shows Positive Results of It...
	Tsinghua: COVID-19 Vaccine and Antibodies Ready for Anim...
	BeyondSpring Initiates NDA Rolling Submission for Plinab...
	Chinese Scientists: Several 'Extremely Effective' Antibo...

	NHSA Releases Its 2019 Healthcare Security Sector Develo...
	China Issues Major Policy for Deepening Medical Insuranc...
	NHSA and MOHRSS Makes Name Changes to Certain Drugs List...
	NHSA and NHC Issues Policy for Internet+ Healthcare Serv...
	China Issues New Policy to Strengthen Pharmacy Affairs a...

	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves
	Recent Executive Moves

	Upcoming Event: 2nd World Congress on Dermatology and Ae...
	Upcoming Event: XI International Exhibition of Equipment...
	China Unveils New Measures to Keep Foreign Trade, Invest...
	AmCham China's Business Climate Survey 2020 - US compani...
	Upcoming Event: 6th Annual Biopharma Development and Pro...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

WiCON Publishes the China Phar...

WiCON to Hold Pharma China Ann...

WiCON Publishes the China Phar...

WiCON Officially Publishes Chi...

Site map | Contact Us | Links